AMPGW yields 2594.03% · JNJ yields 2.13%● Live data
📍 AMPGW pulled ahead of the other in Year 1
Combined, AMPGW + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AMPGW + JNJ for your $10,000?
AmpliTech Group, Inc. designs, engineers, and assembles micro-wave component based amplifiers. The company's products include radio frequency amplifiers and related subsystems, such as low noise amplifiers for use in receivers of various communication systems comprise Wi-Fi, radar, satellite, base station, cell phone, radio, etc.; medium power amplifiers to provide increased output power and gain in transceiver chains; oscillators that consist of phase locked oscillators and dielectric resonator oscillators for transceiver applications; and filters that discriminate or block out frequencies in communication systems. It also provides custom assembly designs and non-recurring engineering services on a project-by-project basis. The company serves aerospace, government, defense, and commercial satellite industries. It sells its products through sales representatives or distributors in North America, Europe, and Asia. AmpliTech Group, Inc. was founded in 2002 and is based in Bohemia, New York.
Full AMPGW Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.